Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 1
2000 2
2001 2
2002 2
2003 1
2004 2
2005 1
2006 6
2007 1
2008 2
2009 4
2010 6
2011 12
2012 8
2013 11
2014 9
2015 16
2016 11
2017 15
2018 14
2019 20
2020 19
2021 24
2022 19
2023 7
2024 14
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study.
Bhatla T, Hogan LE, Teachey DT, Bautista F, Moppett J, Velasco Puyó P, Micalizzi C, Rossig C, Shukla N, Gilad G, Locatelli F, Baruchel A, Zwaan CM, Bezler NS, Rubio-San-Simón A, Taussig DC, Raetz EA, Mao ZJ, Wood BL, Alvarez Arias D, Krevvata M, Nnane I, Bandyopadhyay N, Lopez Solano L, Dennis RM, Carson R, Vora A. Bhatla T, et al. Among authors: rossig c. Blood. 2024 Nov 21;144(21):2237-2247. doi: 10.1182/blood.2024024493. Blood. 2024. PMID: 39158071 Clinical Trial.
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.
Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, Kretschmann S, Völkl S, Hartley J, Dreger C, Petry K, Bosio A, von Döllen A, Hartmann W, Lode H, Görlich D, Mackensen A, Jungblut M, Schambach A, Abken H, Rossig C. Fischer-Riepe L, et al. Among authors: rossig c. Clin Cancer Res. 2024 Aug 15;30(16):3564-3577. doi: 10.1158/1078-0432.CCR-23-3157. Clin Cancer Res. 2024. PMID: 38593230
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas.
Fischer A, Albert TK, Moreno N, Interlandi M, Mormann J, Glaser S, Patil P, de Faria FW, Richter M, Verma A, Balbach ST, Wagener R, Bens S, Dahlum S, Göbel C, Münter D, Inserte C, Graf M, Kremer E, Melcher V, Di Stefano G, Santi R, Chan A, Dogan A, Bush J, Hasselblatt M, Cheng S, Spetalen S, Fosså A, Hartmann W, Herbrüggen H, Robert S, Oyen F, Dugas M, Walter C, Sandmann S, Varghese J, Rossig C, Schüller U, Tzankov A, Pedersen MB, d'Amore FA, Mellgren K, Kontny U, Kancherla V, Veloza L, Missiaglia E, Fataccioli V, Gaulard P, Burkhardt B, Soehnlein O, Klapper W, de Leval L, Siebert R, Kerl K. Fischer A, et al. Among authors: rossig c. Nat Commun. 2024 Oct 3;15(1):8571. doi: 10.1038/s41467-024-52826-0. Nat Commun. 2024. PMID: 39362842 Free PMC article.
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.
Pennesi E, Michels N, Brivio E, van der Velden VHJ, Jiang Y, Thano A, Ammerlaan AJC, Boer JM, Beverloo HB, Sleight B, Chen Y, Vormoor-Bürger B, Rives S, Bielorai B, Rössig C, Petit A, Rizzari C, Engstler G, Starý J, Bautista Sirvent FJ, Chen-Santel C, Bruno B, Bertrand Y, Rialland F, Plat G, Reinhardt D, Vinti L, Von Stackelberg A, Locatelli F, Zwaan CM. Pennesi E, et al. Among authors: rossig c. Leukemia. 2022 Jun;36(6):1516-1524. doi: 10.1038/s41375-022-01576-3. Epub 2022 Apr 25. Leukemia. 2022. PMID: 35468945 Free PMC article. Clinical Trial.
Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma.
Münter D, de Faria FW, Richter M, Aranda-Pardos I, Hotfilder M, Walter C, Paga E, Inserte C, Albert TK, Roy R, Rahman S, Riedel NC, Müller V, Pascher A, Wiebe K, Schmid I, Vokuhl C, Winkler B, Jüttner E, Vieth S, Mücke U, Kluiver TA, Peng WC, Rossig C, Schlué J, Madadi-Sanjani O, Sandmann S, Hartmann W, A-Gonzalez N, Soehnlein O, Kerl K. Münter D, et al. Among authors: rossig c. J Hepatol. 2025 Aug;83(2):367-382. doi: 10.1016/j.jhep.2025.01.031. Epub 2025 Feb 1. J Hepatol. 2025. PMID: 39900120 Free article.
ETMR stem-like state and chemo-resistance are supported by perivascular cells at single-cell resolution.
de Faria FW, Riedel NC, Münter D, Interlandi M, Göbel C, Altendorf L, Richter M, Melcher V, Thomas C, Roy R, Schoof M, Bedzhov I, Moreno N, Graf M, Hotfilder M, Holdhof D, Hartmann W, Bruns AK, Brentrup A, Liesche-Starnecker F, Maerkl B, Sandmann S, Varghese J, Dugas M, Pinto PH, Balbach ST, Lu IN, Rossig C, Soehnlein O, Canak A, Ebinger M, Schuhmann M, Schittenhelm J, Frühwald MF, Schüller U, Albert TK, Walter C, Bruder JM, Kerl K. de Faria FW, et al. Among authors: rossig c. Nat Commun. 2025 Jun 25;16(1):5394. doi: 10.1038/s41467-025-60442-9. Nat Commun. 2025. PMID: 40562749 Free PMC article.
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆.
Gaspar N, Campbell-Hewson Q, Gallego Melcon S, Locatelli F, Venkatramani R, Hecker-Nolting S, Gambart M, Bautista F, Thebaud E, Aerts I, Morland B, Rossig C, Canete Nieto A, Longhi A, Lervat C, Entz-Werle N, Strauss SJ, Marec-Berard P, Okpara CE, He C, Dutta L, Casanova M. Gaspar N, et al. Among authors: rossig c. ESMO Open. 2021 Oct;6(5):100250. doi: 10.1016/j.esmoop.2021.100250. Epub 2021 Sep 22. ESMO Open. 2021. PMID: 34562750 Free PMC article. Clinical Trial.
210 results